Ranibizumab; 2.3 mg/0.23 mL, 1 x 0.23 mL vial, 1.65 mg/0.165 mL, pre-filled syringe; Lucentis® Page last updated: 6 March 2015 Public Summary Document (PSD) November 2014 PBAC Meeting - (PDF 415 KB) Public Summary Document (PSD) November 2014 PBAC Meeting - (Word 204 KB)